Pegylated Abeta Fab

Details for Australian Patent Application No. 2008206555 (hide)

Owner Eli Lilly and Company

Inventors Chow, Chi-Kin; Lu, Jirong; Demattos, Ronald Bradley; Bumol, Thomas Frank; Hansen, Ryan John; Bales, Kelly Renee; McDonnell, Peter Colon; Kuchibhotla, Uma

Agent Spruson & Ferguson

Pub. Number AU-A-2008206555

PCT Pub. Number WO2008/088983

Priority 60/885,439 18.01.07 US

Filing date 9 January 2008

Wipo publication date 24 July 2008

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/088983 Priority application(s): WO2008/088983

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206567-Composition suitable for thin-wall injection molded articles

2008206552-Method and system for measuring a user's level of attention to content